Clinical Trials Directory

Trials / Completed

CompletedNCT03706976

NIRS to Monitor Abdominal Tissue Oxygen Saturation in Preterm Infants

NIRS to Monitor Abdominal Tissue Oxygen Saturation in Preterm Infants in an Open Mono-centric Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Carag AG · Industry
Sex
All
Age
35 Weeks
Healthy volunteers
Not accepted

Summary

The NIRS (near infrared spectroscopy) sensor will be applied to the abdomen of the study population. To ensure good skin contact the sensor will be placed underneath the diaper. If that should not provide enough measurement stability, additional fixation will be given by employing aforementioned flexible bandage routinely employed in neonatal care. Once good skin contact is ensured, the sensor will measure aStO2 (abdominal tissue oxygen saturation) for up to seventy-two hours. The presence of this sensor will not disturb daily clinical activities or medical treatment in any way. Should good skin contact be endangered by movements, clinical interactions or such, the sensor will be removed and re-attached to the infants' abdomen as a consequence.

Conditions

Interventions

TypeNameDescription
DEVICETissue Oxygenation MonitoringThe NIRS sensor will be applied to the abdomen of the study population. To ensure good skin contact the sensor will be placed underneath the diaper. If that should not provide enough measurement stability, additional fixation will be given by employing aforementioned flexible bandage routinely employed in neonatal care. Once good skin contact is ensured, the sensor will measure aStO2 for up to seventy-two hours. The presence of this sensor will not disturb daily clinical activities or medical treatment in any way. Should good skin contact be endangered by movements, clinical interactions or such, the sensor will be removed and re-attached to the infants' abdomen as a consequence.

Timeline

Start date
2019-04-30
Primary completion
2022-11-17
Completion
2022-11-17
First posted
2018-10-16
Last updated
2022-12-20

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03706976. Inclusion in this directory is not an endorsement.